๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The aromatase inhibitors (plus ovarian function suppression) in premenopausal breast cancer patients: Ready for prime time?

โœ Scribed by Montagna, Emilia; Cancello, Giuseppe; Colleoni, Marco

Book ID
123006255
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
324 KB
Volume
39
Category
Article
ISSN
0305-7372

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

32 ASTRRA study: a randomised phase III
32 ASTRRA study: a randomised phase III study for evaluating the role of the addition of ovarian function suppression (OFS) to tamoxifen in young women (<45 years) with hormone-sensitive breast cancer who remain in premenopause or regain menstruation after chemotherapy โ€“ a Korean Breast Cancer Study Group (KBCSG) trial
โœ W.C. Noh; M.H. Hur; S.H. Ahn; Y. Jung; S.J. Lee; E.S. Lee; B.W. Park; J. Jong; S ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 63 KB
5005 ORAL Exploratory Subgroup Analysis
5005 ORAL Exploratory Subgroup Analysis of the TAMRAD Phase 2 GINECO Trial Comparing Tamoxifen (TAM) Plus Everolimus (RAD) With TAM Alone in Patients With Hormone-receptor-positive, HER2-negative Metastatic Breast Cancer (mBC) With Prior Exposure to Aromatase Inhibitors (Als): Implication for Research Strategies
โœ Bourqier, C.; Ray-Coquard, I.; Provencal, J.; Cropet, C.; Bourcier, A.V.; Delecr ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 43 KB